sensation, are major health related problems that increase with age. Considering the large costs associated with LUTS dysfunction there is little understanding of how aging affects normal bladder physiology. Our preliminary studies have revealed that aged urothelium (UT) exhibit altered mitochondrial (MITO) function which we hypothesize leads to altered release of mediators (ATP) culminating in abnormal urodynamic behavior. The objective of this study was designed to elucidate the effects of aging on UT physiology and the impact this has on bladder function.
sensation, are major health related problems that increase with age. Considering the large costs associated with LUTS dysfunction there is little understanding of how aging affects normal bladder physiology. Our preliminary studies have revealed that aged urothelium (UT) exhibit altered mitochondrial (MITO) function which we hypothesize leads to altered release of mediators (ATP) culminating in abnormal urodynamic behavior. The objective of this study was designed to elucidate the effects of aging on UT physiology and the impact this has on bladder function.
METHODS: Bladder function in female F344 rats (3-25mo) was assessed with metabolic (24hr) cages; tactile/abdominal sensitivity was assessed using von Frey filaments. Following these procedures, animals were sacrificed, and bladders collected for cell culture, ATP release and western immunoblotting.
RESULTS: We find that aged rat UT exhibit a significant increase in the senescent marker p16 (2-fold increase) versus UT from younger animals. Further, using Seahorse methodology to examine UT bioenergetics, we find aged UT shows a decrease in both maximal cellular respiration as well as spare respiratory capacity (SRC-extra capacity available to cells to produce energy in response to stress). Aged UT exhibit a decrease in MITO membrane potential (marker of MITO health) and also exhibit a decreased ability to release ATP in response to a mechanical (hypotonic) stimuli as well as decreased overall ATP content. In addition, we also observed a decrease in tactile (abdominal and somatic) stimuli in aged rats as well as decrease in voiding frequency as compared to younger rats.
CONCLUSIONS: Age-related perturbations of the UT could have a significant impact on bladder function via a local UT-afferent signaling pathway that can regulate sensory input to the CNS. MITO are considered major players in energy production and are associated with a number of age-related diseases. Our findings indicate that UT MITO are significantly affected by aging. We propose that dysregulation of MITO dynamics in the aging bladder may lead to defects in UT-afferent signaling that over time ultimately lead to altered sensation and incontinence in the elderly. MicroRNA-29 or miR-29 suppresses translation of genes related to extracellular matrix (ECM) formation, particularly various collagens, collagen cross-linking elements, and enzymes that regulate posttranslational modification of the ECM proteins. Dysregulation of ECM formation results in fibrosis. A recent study comprehensively investigated miRNA abundance and signaling in bladder biopsies from patients with bladder outlet obstruction and found significant increases or decreases in multiple miRNAs, but specifically reported a decrease in miR-29. METHODS: Bladder outlet obstruction (BOO) was created in male C57BL/6 mice, and mice were sacrificed 10 days later. Abundance of miR-29a in the urothelium and detrusor was determined, as was abundance of mRNA encoding for transforming growth factor-b (TGFb), collagen 1a1 (col 1a1), collagen 4a1 (col 4a1), connective tissue growth factor (CTGF), fibronectin-1 (FBN1), and laminin C1 (LAM). In two other groups, mice were injected with miR-29a mimic or vehicle (6 treatments at 25 µg/treatment given ip beginning 24 hr before creation of BOO, repeated on the day of surgery, and 2, 4, 6, and 8 days after surgery) and sacrificed 10 days after creation of BOO.
RESULTS: The abundance of miR-29a was decreased in the detrusor, but not the urothelium, after 10 days of BOO. mRNA encoding for TGFb, col 1a1, col 4a1, FBN1, and LAM were all ignificantly increased in the detrusor of mice with BOO compared to sham-operated controls. Message for CTGF was increased in both the detrusor and urothelium. Injection of mice with miR-29a mimic decreased message for col 1a1 and LAM in both the urothelium and detrusor, as well as message for FBN1 in the detrusor, compared to BOO mice treated with vehicle.
CONCLUSIONS: These results indicate: 1. abundance of miR29a is decreased by BOO; and 2. miR-29a has the capacity to decrease message for components of fibrosis in the presence of BOO. Further research is required, but these experiments support consideration of miR-29a as a potential therapy to prevent or treat BOO-associated bladder fibrosis.
Source of Funding: NIH U54DK104310; NIH R01DK084059
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INTRODUCTION AND OBJECTIVES: Underactive bladder is a consequence of late-stage diabetes with decreased bladder contractility and increased post void residual urine. This study evaluates the therapeutic effect of once-per-week low-intensity extracorporeal shock wave therapy (Li-ESWT) on underactive bladder in the diabetic rat model. METHODS: Thirty-six female Sprague-Dawley rats were assigned into 3 groups: normal control (NC), diabetes control (DMC), and diabetes underwent Li-ESWT (DM Li-ESWT). The two DM groups received intraperitoneal streptozotocin to induce diabetes mellitus. Li-ESWT toward the pelvis of the rats was applied in DM Li-ESWT group once-per-week (0.02 mJ/mm2 at 3 Hz for 400 pulses) for 4 weeks. All rats were subjected to cystometry, leak point pressure, ex-vivo organ bath study, histology, western blot analysis, and immunofluorescence.
RESULTS: Cystometry revealed significant improvement in the DM Li-ESWT group with reduced post-void residual urine (0.30 vs 0.91mL, p<0.01), and increased leak point pressure (38.2 vs 31.3 cmH2O, p<0.01) compared to DMC group. Ex-vivo organ bath study showed that Li-ESWT enhances muscle contractile activity of bladder in electrical field stimulation and drug stimulation. Histologically, Li-ESWT significantly restored bladder morphology-reducing intravesical lumen area and increasing muscle proportion. Western blot analysis showed higher smooth muscle actin expression in DM Li-ESWT compared to DMC group. Immunofluorescence demonstrated restored neuronal integrity and innervation in DM Li-ESWT group.
CONCLUSIONS: In conclusion, once-per-week Li-ESWT ameliorated the bladder function in the diabetic underactive bladder rat model. Li-ESWT improved bladder wall composition, activated bladder muscle regeneration, enhanced bladder muscle contractile function, increased bladder nerve innervation and promoted continence. Further investigations are encouraged for the potential clinical application.
Source of Funding: Support by NIDDK of the National Institutes of Health under award number R56DK105097 and
